Last update 01 Nov 2024

Esepapogene Zalarnarepvec

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
TheraT LCMV, TheraT-E7E6(Hookipa)
+ [2]
Mechanism
E7 inhibitors(Protein E7 inhibitors), HPV E6 inhibitors(HPV E6 inhibitors), Immunostimulants
Therapeutic Areas
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Human Papillomavirus-Related Squamous Cell CarcinomaPhase 2
ES
11 Dec 2019
Human Papillomavirus-Related Squamous Cell CarcinomaPhase 2
US
11 Dec 2019
Human Papillomavirus-Related Squamous Cell CarcinomaPhase 2
NL
11 Dec 2019
Recurrent Squamous Cell Carcinoma of the Head and NeckPhase 2
US
11 Dec 2019
Recurrent Squamous Cell Carcinoma of the Head and NeckPhase 2
ES
11 Dec 2019
Recurrent Squamous Cell Carcinoma of the Head and NeckPhase 2
NL
11 Dec 2019
NeoplasmsPhase 2--
Oropharyngeal NeoplasmsDiscovery
US
15 Feb 2021
Uterine Cervical CancerDiscovery
US
15 Feb 2021
Human Papillomavirus InfectionDiscovery
US
11 Dec 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
-
irufovezda(zwawjfmhfa) = laayxaajsl apodqyfszs (svoppwpvsf )
-
15 Jun 2022
irufovezda(zwawjfmhfa) = uegfbjawkn apodqyfszs (svoppwpvsf )
Phase 1
HPV-related carcinoma
HPV16 positive
65
(mxlvrnmeyf) = Preliminary safety, efficacy, and immunogenicity data support IV injection of DL3 (5 × 107 units) every 3 weeks (Q3W) as the RP2D for HB-201 single-vector therapy. RP2D for HB-202/HB-201 will be determined in the very near future. jpixvqlnaf (fgmdcoeeiq )
Positive
02 Jun 2022
Phase 1/2
62
(huonfzqckj) = cegsluupyk qucgirnkrv (pijjetowmr )
Positive
09 Nov 2021
(huonfzqckj) = sqgzobixgp qucgirnkrv (pijjetowmr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free